Gamma Investing LLC Halozyme Therapeutics, Inc. Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 517 shares of HALO stock, worth $31,562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
517
Previous 263
96.58%
Holding current value
$31,562
Previous $10.7 Million
153.01%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
489Shares Held
122MCall Options Held
208KPut Options Held
66.3K-
Black Rock Inc. New York, NY17.6MShares$1.08 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$786 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$355 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$247 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$227 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.5B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...